Eyenuk vs Viz.ai
Eyenuk's pages sell diabetic eye screening and Viz.ai's sell stroke, vascular and cardiac coordination, so a health system could hold both contracts. Eyenuk lists Temple Health, Nebraska Medicine and University of Kentucky HealthCare as customers and says EyeArt has integrated with multiple major EHR systems, including Epic, taking orders in and sending reports out. The press release on its prospective multicenter trial, NCT04984200, reports 94.4% sensitivity and 91.1% specificity for more than mild diabetic retinopathy.
Viz.ai fits a hospital stroke program, with the Viz Neuro suite alerting care teams to suspected LVO, hemorrhage and aneurysm. ContaCT was authorized through De Novo DEN170073 on February 13, 2018, and the vendor says Viz.ai is embedded in 2,000 hospitals. A 2025 meta-analysis of 12 studies and 15,595 patients found shorter door-to-groin times with Viz.ai and no significant difference in clinical outcomes. The Trust Center lists SOC 2 Type II and ISO 27001.
Radiology · Reviewed November 2, 2026
When to pick each one
Eyenuk
- Vendor says Epic orders in, reports out
- Adults with diabetes and no prior retinopathy diagnosis
Viz.ai
- Stroke, vascular and cardiac alerts to care teams
- Trust Center lists SOC 2 Type II and ISO 27001
- Pooled data shows faster door-to-groin times
Score
Each row shows points earned of points available under the published rubric.
Eyenuk
71of 100
Viz.ai
89of 100
| Dimension | Eyenuk | Viz.ai | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 10 / 10 | 10 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 18.2 / 18.2 | 18.2 / 18.2 | 0 |
| RCT / meta-analysis / systematic review | 7.8 / 7.8 | 7.8 / 7.8 | 0 |
| Funding & adoption signal | 3 / 12 | 12 / 12 | -9 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 6 / 6 | -6 |
Scroll horizontally to see every column.
Pricing
Eyenuk
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Viz.ai
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Sold to health systems after a demo request. |
Evidence
Eyenuk
FDA decisions
K223357 (opens in new tab)510(k)2023-06-16
EyeArt v2.2.0
K200667 (opens in new tab)510(k)2020-08-03
EyeArt
Peer-reviewed
5 PubMed records name Eyenuk.
- Diagnostic Accuracy of the EyeArt Artificial Intelligence System for Diabetic Retinopathy: A Systematic Review and Meta-Analysis. (opens in new tab)
- A pilot cost-analysis study comparing AI-based EyeArt® and ophthalmologist assessment of diabetic retinopathy in minority women in Oslo, Norway. (opens in new tab)
- [Use of Artificial Intelligence in Diabetic Retinopathy Screening: Experience in a Health Service in Santiago, Chile]. (opens in new tab)
Viz.ai
FDA decisions
K250354 (opens in new tab)510(k)2025-06-10
Viz Subdural+
K232363 (opens in new tab)510(k)2024-02-05
Viz HDS, Viz Volume Plus, Viz ICH+
DEN230003 (opens in new tab)De Novo2023-08-03
Viz HCM
K223443 (opens in new tab)510(k)2023-03-17
Viz AAA
K223042 (opens in new tab)510(k)2022-10-21
Viz LVO (ContaCT)
Show 7 more
K221100 (opens in new tab)510(k)2022-08-29
Viz RV/LV
K220439 (opens in new tab)510(k)2022-07-25
Viz SDH
K213319 (opens in new tab)510(k)2022-02-18
Viz ANEURYSM
K210209 (opens in new tab)510(k)2021-03-23
Viz ICH
K193658 (opens in new tab)510(k)2020-03-18
Viz ICH
K180161 (opens in new tab)510(k)2018-04-20
Viz CTP
DEN170073 (opens in new tab)De Novo2018-02-13
ContaCT
Peer-reviewed
5 PubMed records name Viz.ai.
- Automated Emergent Large Vessel Occlusion Detection Using Viz.ai Software and Its Impact on Stroke Workflow Metrics and Patient Outcomes in Stroke Centers: A Systematic Review and Meta-analysis. (opens in new tab)
- Revolutionizing Intracranial Hemorrhage Diagnosis: A Retrospective Analytical Study of Viz.ai ICH for Enhanced Diagnostic Accuracy. (opens in new tab)
- Real-world evaluation of the accuracy of the Viz.AI automated intracranial hemorrhage volume calculation tool. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Eyenuk | Viz.ai |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 2016 |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.